| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Myocardium | 117 | 2017 | 983 | 4.950 |
Why?
|
| Fibroblasts | 28 | 2017 | 882 | 3.570 |
Why?
|
| Myocardial Reperfusion Injury | 22 | 2013 | 144 | 2.610 |
Why?
|
| Aging | 23 | 2022 | 1164 | 2.320 |
Why?
|
| Myocardial Ischemia | 22 | 2015 | 330 | 2.260 |
Why?
|
| Fibrosis | 32 | 2022 | 429 | 2.200 |
Why?
|
| Myocardial Infarction | 30 | 2013 | 996 | 1.920 |
Why?
|
| Sarcoplasmic Reticulum | 47 | 2013 | 196 | 1.790 |
Why?
|
| Dogs | 119 | 2006 | 774 | 1.530 |
Why?
|
| Heart | 36 | 2016 | 725 | 1.480 |
Why?
|
| Neutrophils | 33 | 2006 | 373 | 1.370 |
Why?
|
| Aminoimidazole Carboxamide | 5 | 2022 | 24 | 1.320 |
Why?
|
| Ribonucleotides | 5 | 2018 | 36 | 1.300 |
Why?
|
| Animals | 261 | 2022 | 33888 | 1.290 |
Why?
|
| Chemokine CCL2 | 13 | 2017 | 113 | 1.280 |
Why?
|
| Inflammation | 20 | 2021 | 1398 | 1.250 |
Why?
|
| AMP-Activated Protein Kinases | 6 | 2022 | 166 | 1.210 |
Why?
|
| Mice, Inbred C57BL | 53 | 2021 | 4385 | 1.140 |
Why?
|
| Myocardial Reperfusion | 17 | 2006 | 73 | 1.130 |
Why?
|
| Coronary Disease | 30 | 2002 | 631 | 1.040 |
Why?
|
| Mice | 105 | 2022 | 17628 | 1.020 |
Why?
|
| Interleukin-6 | 9 | 2015 | 394 | 1.010 |
Why?
|
| Cardiomegaly | 12 | 2018 | 136 | 1.010 |
Why?
|
| Myofibroblasts | 11 | 2017 | 75 | 0.970 |
Why?
|
| Monocytes | 9 | 2015 | 348 | 0.960 |
Why?
|
| Cell Differentiation | 13 | 2014 | 1936 | 0.960 |
Why?
|
| Cardiomyopathies | 9 | 2022 | 481 | 0.960 |
Why?
|
| Reperfusion Injury | 10 | 2017 | 102 | 0.950 |
Why?
|
| Angiotensin II | 8 | 2017 | 161 | 0.920 |
Why?
|
| Ventricular Remodeling | 17 | 2018 | 175 | 0.880 |
Why?
|
| Calcium | 48 | 2013 | 1096 | 0.880 |
Why?
|
| Myocytes, Cardiac | 19 | 2019 | 618 | 0.850 |
Why?
|
| Cicatrix | 4 | 2013 | 125 | 0.840 |
Why?
|
| Coronary Vessels | 26 | 2013 | 525 | 0.840 |
Why?
|
| Cell Adhesion Molecules | 15 | 2004 | 226 | 0.820 |
Why?
|
| Cells, Cultured | 31 | 2019 | 3076 | 0.750 |
Why?
|
| Intercellular Adhesion Molecule-1 | 18 | 2002 | 133 | 0.720 |
Why?
|
| Muscles | 25 | 1993 | 289 | 0.680 |
Why?
|
| Lymph | 18 | 2000 | 25 | 0.670 |
Why?
|
| Tumor Necrosis Factor-alpha | 15 | 2016 | 670 | 0.670 |
Why?
|
| Cytokines | 13 | 2015 | 1288 | 0.660 |
Why?
|
| Mast Cells | 8 | 2005 | 75 | 0.660 |
Why?
|
| Inflammation Mediators | 5 | 2016 | 233 | 0.650 |
Why?
|
| Cell Lineage | 4 | 2017 | 348 | 0.640 |
Why?
|
| Chemokines | 6 | 2006 | 137 | 0.620 |
Why?
|
| Mice, Knockout | 32 | 2021 | 3776 | 0.610 |
Why?
|
| Myeloid Cells | 2 | 2015 | 99 | 0.600 |
Why?
|
| Collagen | 16 | 2022 | 312 | 0.600 |
Why?
|
| Collagen Type I | 3 | 2014 | 110 | 0.580 |
Why?
|
| Disease Models, Animal | 26 | 2021 | 4313 | 0.570 |
Why?
|
| Coronary Circulation | 15 | 2010 | 208 | 0.540 |
Why?
|
| Endothelium, Vascular | 19 | 2005 | 514 | 0.520 |
Why?
|
| Cell-Derived Microparticles | 1 | 2016 | 31 | 0.520 |
Why?
|
| Blood Flow Velocity | 16 | 2021 | 448 | 0.500 |
Why?
|
| Calcium-Transporting ATPases | 16 | 1993 | 54 | 0.500 |
Why?
|
| Kidney | 9 | 2017 | 1345 | 0.500 |
Why?
|
| rho-Associated Kinases | 6 | 2013 | 55 | 0.500 |
Why?
|
| Male | 101 | 2022 | 59592 | 0.480 |
Why?
|
| RNA, Messenger | 25 | 2010 | 2833 | 0.480 |
Why?
|
| Procollagen | 1 | 2014 | 9 | 0.480 |
Why?
|
| Ultrasonography, Doppler | 10 | 2015 | 197 | 0.470 |
Why?
|
| Myocardial Contraction | 12 | 2021 | 261 | 0.470 |
Why?
|
| Multipotent Stem Cells | 2 | 2011 | 29 | 0.470 |
Why?
|
| Nuclear Receptor Coactivator 2 | 4 | 2018 | 203 | 0.470 |
Why?
|
| Cell Movement | 13 | 2011 | 839 | 0.470 |
Why?
|
| Heart Failure | 13 | 2014 | 2125 | 0.460 |
Why?
|
| Peptide Fragments | 4 | 2014 | 745 | 0.460 |
Why?
|
| Gene Expression Regulation | 15 | 2014 | 2541 | 0.460 |
Why?
|
| Insulin | 15 | 2015 | 1186 | 0.450 |
Why?
|
| Chemokines, CXC | 2 | 2006 | 39 | 0.440 |
Why?
|
| Wound Healing | 6 | 2013 | 454 | 0.440 |
Why?
|
| C-Reactive Protein | 1 | 2016 | 402 | 0.430 |
Why?
|
| Signal Transduction | 14 | 2017 | 4511 | 0.420 |
Why?
|
| Ventricular Function, Left | 8 | 2021 | 500 | 0.420 |
Why?
|
| Macrophage-1 Antigen | 11 | 2002 | 27 | 0.420 |
Why?
|
| Myeloid Progenitor Cells | 1 | 2012 | 15 | 0.420 |
Why?
|
| Endothelial Cells | 2 | 2016 | 528 | 0.410 |
Why?
|
| Macrophages | 13 | 2017 | 616 | 0.410 |
Why?
|
| Bone Marrow Cells | 3 | 2011 | 261 | 0.410 |
Why?
|
| Hemodynamics | 13 | 2014 | 839 | 0.410 |
Why?
|
| Peripheral Arterial Disease | 1 | 2016 | 266 | 0.400 |
Why?
|
| Reactive Oxygen Species | 5 | 2006 | 480 | 0.400 |
Why?
|
| Mitochondria, Heart | 12 | 1994 | 60 | 0.390 |
Why?
|
| Myocarditis | 4 | 2004 | 119 | 0.390 |
Why?
|
| Peptides | 1 | 2014 | 801 | 0.360 |
Why?
|
| Biomarkers | 9 | 2017 | 2942 | 0.360 |
Why?
|
| Heart Rate | 15 | 2021 | 583 | 0.350 |
Why?
|
| Heart Ventricles | 15 | 2017 | 767 | 0.350 |
Why?
|
| Platelet Aggregation | 5 | 2013 | 120 | 0.350 |
Why?
|
| Hypertension, Pulmonary | 1 | 2014 | 428 | 0.330 |
Why?
|
| Leukocytes, Mononuclear | 2 | 2009 | 326 | 0.330 |
Why?
|
| Vasoconstrictor Agents | 1 | 2010 | 138 | 0.330 |
Why?
|
| Heart Atria | 5 | 2021 | 308 | 0.320 |
Why?
|
| Time Factors | 27 | 2014 | 6176 | 0.320 |
Why?
|
| Kidney Diseases | 4 | 2016 | 479 | 0.310 |
Why?
|
| Cell Transdifferentiation | 1 | 2009 | 67 | 0.310 |
Why?
|
| Adenosine Triphosphate | 18 | 1993 | 288 | 0.310 |
Why?
|
| Transforming Growth Factor beta | 4 | 2015 | 459 | 0.310 |
Why?
|
| Enzyme Activation | 11 | 2013 | 620 | 0.310 |
Why?
|
| Muscle Proteins | 10 | 2014 | 416 | 0.310 |
Why?
|
| Receptors, IgG | 1 | 2008 | 57 | 0.300 |
Why?
|
| Receptors, Adrenergic, beta | 5 | 2015 | 58 | 0.300 |
Why?
|
| Macrophage Colony-Stimulating Factor | 3 | 2003 | 22 | 0.300 |
Why?
|
| Extracellular Matrix | 7 | 2017 | 232 | 0.300 |
Why?
|
| Aorta | 5 | 2021 | 534 | 0.300 |
Why?
|
| Receptors, Chemokine | 1 | 2007 | 44 | 0.280 |
Why?
|
| Receptors, CCR2 | 3 | 2013 | 23 | 0.280 |
Why?
|
| Flow Cytometry | 7 | 2016 | 810 | 0.280 |
Why?
|
| Female | 78 | 2022 | 64958 | 0.280 |
Why?
|
| CD18 Antigens | 12 | 2002 | 49 | 0.270 |
Why?
|
| Chemokine CXCL6 | 4 | 2014 | 16 | 0.270 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type I | 3 | 2016 | 29 | 0.260 |
Why?
|
| Glycogen | 10 | 1985 | 64 | 0.260 |
Why?
|
| Receptors, CXCR | 3 | 2014 | 7 | 0.260 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 4 | 2019 | 551 | 0.260 |
Why?
|
| Kinetics | 30 | 1997 | 1316 | 0.250 |
Why?
|
| Cell Adhesion | 19 | 1999 | 321 | 0.250 |
Why?
|
| Immunoglobulin M | 1 | 2006 | 210 | 0.250 |
Why?
|
| In Vitro Techniques | 20 | 2013 | 968 | 0.250 |
Why?
|
| Thrombospondin 1 | 1 | 2005 | 22 | 0.250 |
Why?
|
| Arteriosclerosis | 2 | 2002 | 139 | 0.250 |
Why?
|
| Antigens, CD | 7 | 2002 | 421 | 0.250 |
Why?
|
| Interleukin-8 | 4 | 1996 | 209 | 0.240 |
Why?
|
| Lymphocyte Function-Associated Antigen-1 | 6 | 2002 | 27 | 0.230 |
Why?
|
| Chemokine CCL5 | 1 | 2004 | 55 | 0.230 |
Why?
|
| Verapamil | 7 | 1987 | 52 | 0.230 |
Why?
|
| Humans | 77 | 2021 | 122410 | 0.220 |
Why?
|
| Chemotaxis, Leukocyte | 7 | 1999 | 61 | 0.220 |
Why?
|
| Ventricular Dysfunction, Left | 6 | 2018 | 366 | 0.220 |
Why?
|
| Cyclic AMP | 14 | 2004 | 248 | 0.220 |
Why?
|
| Diastole | 7 | 2017 | 170 | 0.220 |
Why?
|
| Guanosine Triphosphate | 6 | 1989 | 47 | 0.220 |
Why?
|
| Homeodomain Proteins | 3 | 2013 | 547 | 0.220 |
Why?
|
| Carotid Arteries | 6 | 2004 | 151 | 0.210 |
Why?
|
| Laser-Doppler Flowmetry | 2 | 2011 | 56 | 0.210 |
Why?
|
| Rabbits | 16 | 1994 | 717 | 0.210 |
Why?
|
| Regeneration | 1 | 2005 | 202 | 0.210 |
Why?
|
| Complement Activation | 4 | 2002 | 52 | 0.210 |
Why?
|
| Hypertension | 6 | 2014 | 1265 | 0.210 |
Why?
|
| Nephrosclerosis | 2 | 2013 | 7 | 0.210 |
Why?
|
| Phosphorylases | 8 | 1985 | 15 | 0.210 |
Why?
|
| Cardiovascular Physiological Phenomena | 2 | 2018 | 31 | 0.210 |
Why?
|
| Nanog Homeobox Protein | 2 | 2013 | 27 | 0.200 |
Why?
|
| Ventricular Pressure | 2 | 2021 | 43 | 0.200 |
Why?
|
| Blood Pressure | 12 | 2014 | 1300 | 0.200 |
Why?
|
| Phospholipids | 6 | 1991 | 107 | 0.200 |
Why?
|
| Receptors, Transforming Growth Factor beta | 2 | 2013 | 109 | 0.200 |
Why?
|
| Mitogen-Activated Protein Kinase 7 | 1 | 2021 | 6 | 0.200 |
Why?
|
| Heart Diseases | 4 | 2016 | 479 | 0.200 |
Why?
|
| Cardiomyopathy, Dilated | 4 | 2012 | 214 | 0.190 |
Why?
|
| Immunohistochemistry | 11 | 2010 | 1714 | 0.190 |
Why?
|
| Superoxide Dismutase | 5 | 2006 | 141 | 0.190 |
Why?
|
| Necrosis | 7 | 2006 | 212 | 0.190 |
Why?
|
| Cell Count | 3 | 2017 | 253 | 0.190 |
Why?
|
| Poly(ADP-ribose) Polymerases | 1 | 2021 | 56 | 0.190 |
Why?
|
| Aorta, Thoracic | 2 | 1997 | 517 | 0.190 |
Why?
|
| Phenotype | 10 | 2022 | 4218 | 0.180 |
Why?
|
| Microcirculation | 3 | 2006 | 93 | 0.180 |
Why?
|
| Phosphorylation | 6 | 2021 | 1615 | 0.180 |
Why?
|
| Base Sequence | 9 | 2003 | 3118 | 0.180 |
Why?
|
| Apoptosis | 8 | 2011 | 1795 | 0.180 |
Why?
|
| Molecular Sequence Data | 10 | 2000 | 3887 | 0.180 |
Why?
|
| NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2021 | 112 | 0.180 |
Why?
|
| Endotoxemia | 1 | 2000 | 57 | 0.170 |
Why?
|
| Up-Regulation | 3 | 2016 | 872 | 0.170 |
Why?
|
| Stem Cells | 4 | 2011 | 710 | 0.170 |
Why?
|
| Sarcolemma | 10 | 1994 | 24 | 0.170 |
Why?
|
| GTP Phosphohydrolases | 3 | 1991 | 142 | 0.170 |
Why?
|
| Arteries | 2 | 2011 | 220 | 0.170 |
Why?
|
| Inflammasomes | 1 | 2021 | 149 | 0.170 |
Why?
|
| Infarction | 1 | 2019 | 23 | 0.160 |
Why?
|
| Angina, Unstable | 2 | 1996 | 51 | 0.160 |
Why?
|
| Mice, Transgenic | 12 | 2019 | 2441 | 0.160 |
Why?
|
| Myocardial Stunning | 3 | 2004 | 21 | 0.160 |
Why?
|
| Blood Platelets | 5 | 2013 | 327 | 0.160 |
Why?
|
| Doxorubicin | 2 | 2019 | 307 | 0.160 |
Why?
|
| Obesity | 3 | 2021 | 1949 | 0.160 |
Why?
|
| Models, Biological | 5 | 2011 | 1439 | 0.160 |
Why?
|
| Stem Cell Factor | 1 | 1998 | 14 | 0.160 |
Why?
|
| Leukocyte Common Antigens | 2 | 2010 | 91 | 0.160 |
Why?
|
| Thromboxane B2 | 2 | 1990 | 20 | 0.160 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 4 | 2016 | 815 | 0.160 |
Why?
|
| Leukocytes | 7 | 2006 | 204 | 0.150 |
Why?
|
| Receptors, Leukocyte-Adhesion | 5 | 1994 | 9 | 0.150 |
Why?
|
| Diet Therapy | 1 | 2018 | 39 | 0.150 |
Why?
|
| Rats | 20 | 2015 | 3660 | 0.150 |
Why?
|
| Cytoplasmic Granules | 1 | 1998 | 47 | 0.150 |
Why?
|
| Phagocytes | 1 | 1997 | 24 | 0.150 |
Why?
|
| Acetylcysteine | 1 | 2018 | 74 | 0.150 |
Why?
|
| Amino Acid Sequence | 8 | 1999 | 2701 | 0.150 |
Why?
|
| Glucose | 9 | 2013 | 876 | 0.150 |
Why?
|
| Oxalates | 12 | 1993 | 32 | 0.150 |
Why?
|
| Ventricular Fibrillation | 4 | 1990 | 51 | 0.150 |
Why?
|
| Antibodies, Monoclonal | 13 | 2002 | 1022 | 0.150 |
Why?
|
| Pulse | 2 | 1997 | 30 | 0.150 |
Why?
|
| Dicarboxylic Acids | 2 | 1991 | 34 | 0.150 |
Why?
|
| Insulin-Like Growth Factor I | 3 | 2013 | 340 | 0.150 |
Why?
|
| Glycine | 1 | 2018 | 167 | 0.140 |
Why?
|
| Manometry | 1 | 1997 | 48 | 0.140 |
Why?
|
| In Situ Hybridization | 6 | 2003 | 474 | 0.140 |
Why?
|
| Ureteral Obstruction | 4 | 2017 | 108 | 0.140 |
Why?
|
| MicroRNAs | 3 | 2013 | 837 | 0.140 |
Why?
|
| Liver | 14 | 1988 | 1858 | 0.140 |
Why?
|
| Complement C1 | 2 | 1994 | 4 | 0.140 |
Why?
|
| Propranolol | 10 | 1990 | 128 | 0.140 |
Why?
|
| Cardiomyopathy, Hypertrophic | 3 | 2004 | 152 | 0.140 |
Why?
|
| Image Interpretation, Computer-Assisted | 2 | 2010 | 215 | 0.140 |
Why?
|
| Microsomes | 9 | 1986 | 56 | 0.140 |
Why?
|
| Aorta, Abdominal | 1 | 1997 | 120 | 0.140 |
Why?
|
| Hypertrophy, Left Ventricular | 2 | 2017 | 107 | 0.140 |
Why?
|
| Regional Blood Flow | 11 | 2011 | 212 | 0.140 |
Why?
|
| Pulsatile Flow | 4 | 2011 | 133 | 0.140 |
Why?
|
| Extracellular Matrix Proteins | 3 | 2006 | 149 | 0.130 |
Why?
|
| Coronary Artery Disease | 2 | 2021 | 743 | 0.130 |
Why?
|
| Catalase | 3 | 2006 | 50 | 0.130 |
Why?
|
| Hyperthyroidism | 1 | 1996 | 26 | 0.130 |
Why?
|
| Fluoresceins | 3 | 1997 | 35 | 0.130 |
Why?
|
| Gene Expression | 8 | 2014 | 1591 | 0.130 |
Why?
|
| Heart Failure, Diastolic | 1 | 2015 | 11 | 0.130 |
Why?
|
| Cardiopulmonary Bypass | 5 | 1993 | 342 | 0.130 |
Why?
|
| Chemotactic Factors | 5 | 1996 | 17 | 0.130 |
Why?
|
| Muscular Dystrophy, Animal | 3 | 1997 | 14 | 0.130 |
Why?
|
| Cardiac Output, Low | 2 | 2003 | 66 | 0.130 |
Why?
|
| Atrial Function, Left | 1 | 2015 | 27 | 0.130 |
Why?
|
| Hypoxia-Inducible Factor-Proline Dioxygenases | 1 | 2015 | 23 | 0.130 |
Why?
|
| Procollagen-Proline Dioxygenase | 1 | 2015 | 35 | 0.120 |
Why?
|
| Muscle, Smooth, Vascular | 4 | 2004 | 239 | 0.120 |
Why?
|
| Pulmonary Artery | 2 | 2015 | 441 | 0.120 |
Why?
|
| Thiocyanates | 2 | 1991 | 10 | 0.120 |
Why?
|
| Intracellular Membranes | 2 | 1993 | 64 | 0.120 |
Why?
|
| Atrial Fibrillation | 3 | 2021 | 622 | 0.120 |
Why?
|
| Pericytes | 2 | 2013 | 23 | 0.120 |
Why?
|
| Heart-Assist Devices | 5 | 2004 | 1022 | 0.120 |
Why?
|
| Muscle Contraction | 8 | 1992 | 186 | 0.120 |
Why?
|
| Coronary Thrombosis | 1 | 1994 | 33 | 0.120 |
Why?
|
| Trans-Activators | 2 | 2017 | 805 | 0.120 |
Why?
|
| Dietary Supplements | 1 | 2018 | 456 | 0.120 |
Why?
|
| Heart Transplantation | 4 | 2014 | 854 | 0.120 |
Why?
|
| Cardiolipins | 1 | 1994 | 19 | 0.120 |
Why?
|
| Extracellular Space | 3 | 1997 | 89 | 0.120 |
Why?
|
| Tissue Inhibitor of Metalloproteinase-1 | 1 | 2014 | 37 | 0.120 |
Why?
|
| T-Lymphocytes | 4 | 2014 | 1678 | 0.120 |
Why?
|
| Caspases | 2 | 2006 | 160 | 0.120 |
Why?
|
| Age Factors | 4 | 2017 | 2782 | 0.120 |
Why?
|
| Heart Arrest, Induced | 3 | 1985 | 73 | 0.110 |
Why?
|
| Pericardial Effusion | 1 | 2014 | 64 | 0.110 |
Why?
|
| Phosphoric Monoester Hydrolases | 2 | 1985 | 100 | 0.110 |
Why?
|
| Hydrogen Peroxide | 4 | 2019 | 113 | 0.110 |
Why?
|
| Stress, Physiological | 2 | 2015 | 265 | 0.110 |
Why?
|
| Interleukin-1 | 4 | 2000 | 141 | 0.110 |
Why?
|
| Calcium-Binding Proteins | 1 | 2015 | 328 | 0.110 |
Why?
|
| Stress, Psychological | 3 | 1987 | 550 | 0.110 |
Why?
|
| Phosphatidylserines | 1 | 2013 | 47 | 0.110 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2014 | 138 | 0.110 |
Why?
|
| Hypertension, Renal | 1 | 2013 | 37 | 0.110 |
Why?
|
| Nephritis | 1 | 2013 | 20 | 0.110 |
Why?
|
| Echocardiography, Doppler, Pulsed | 2 | 2021 | 19 | 0.110 |
Why?
|
| Chemokine CXCL16 | 4 | 2014 | 11 | 0.110 |
Why?
|
| Mice, Mutant Strains | 4 | 2013 | 388 | 0.110 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2016 | 1301 | 0.110 |
Why?
|
| Transcription Factors | 4 | 2017 | 2588 | 0.110 |
Why?
|
| Case-Control Studies | 2 | 2021 | 3231 | 0.110 |
Why?
|
| Aging, Premature | 1 | 2013 | 32 | 0.110 |
Why?
|
| Glucagon | 10 | 1988 | 187 | 0.110 |
Why?
|
| Swine | 8 | 1995 | 1158 | 0.110 |
Why?
|
| Detergents | 2 | 1991 | 23 | 0.110 |
Why?
|
| Vasculitis | 1 | 1993 | 49 | 0.110 |
Why?
|
| Dystrophin | 2 | 2004 | 37 | 0.110 |
Why?
|
| Analysis of Variance | 3 | 2011 | 995 | 0.110 |
Why?
|
| Stroke Volume | 8 | 2011 | 448 | 0.110 |
Why?
|
| Death, Sudden | 2 | 1987 | 46 | 0.110 |
Why?
|
| Microvessels | 1 | 2013 | 56 | 0.110 |
Why?
|
| Neovascularization, Pathologic | 4 | 2017 | 240 | 0.110 |
Why?
|
| Adiponectin | 1 | 2013 | 107 | 0.110 |
Why?
|
| Green Fluorescent Proteins | 1 | 2014 | 392 | 0.100 |
Why?
|
| Biological Transport, Active | 10 | 1993 | 87 | 0.100 |
Why?
|
| Receptor, Platelet-Derived Growth Factor beta | 2 | 2010 | 19 | 0.100 |
Why?
|
| Growth Hormone | 1 | 2013 | 151 | 0.100 |
Why?
|
| Cell Separation | 2 | 2011 | 237 | 0.100 |
Why?
|
| Physical Conditioning, Animal | 1 | 1993 | 92 | 0.100 |
Why?
|
| Myosin Heavy Chains | 5 | 2005 | 77 | 0.100 |
Why?
|
| Calcium Channels | 1 | 1993 | 160 | 0.100 |
Why?
|
| Endoplasmic Reticulum Stress | 1 | 2013 | 122 | 0.100 |
Why?
|
| Blotting, Northern | 3 | 1999 | 260 | 0.100 |
Why?
|
| Cell Division | 4 | 2003 | 794 | 0.100 |
Why?
|
| Fatty Acids | 6 | 2008 | 338 | 0.100 |
Why?
|
| Phosphorylase a | 2 | 1983 | 5 | 0.100 |
Why?
|
| P-Selectin | 6 | 1999 | 77 | 0.100 |
Why?
|
| Indoles | 1 | 2013 | 182 | 0.100 |
Why?
|
| Apolipoproteins E | 3 | 2009 | 188 | 0.100 |
Why?
|
| Interleukin-10 | 2 | 2006 | 172 | 0.100 |
Why?
|
| Transfection | 3 | 2009 | 1076 | 0.100 |
Why?
|
| Polymerase Chain Reaction | 2 | 2010 | 1593 | 0.100 |
Why?
|
| Bone Marrow | 1 | 2013 | 319 | 0.100 |
Why?
|
| Transcriptional Activation | 3 | 2017 | 483 | 0.100 |
Why?
|
| Antigens, Surface | 2 | 2002 | 123 | 0.100 |
Why?
|
| Pyrroles | 1 | 2013 | 177 | 0.100 |
Why?
|
| Cell Proliferation | 2 | 2011 | 2315 | 0.100 |
Why?
|
| Middle Aged | 12 | 2016 | 25591 | 0.100 |
Why?
|
| Pilot Projects | 1 | 2016 | 1364 | 0.100 |
Why?
|
| Renal Insufficiency, Chronic | 2 | 2017 | 714 | 0.100 |
Why?
|
| MAP Kinase Kinase Kinases | 1 | 2011 | 48 | 0.090 |
Why?
|
| Fibrillar Collagens | 1 | 2011 | 15 | 0.090 |
Why?
|
| Jugular Veins | 3 | 2003 | 75 | 0.090 |
Why?
|
| Protein Binding | 8 | 1995 | 1736 | 0.090 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2013 | 207 | 0.090 |
Why?
|
| Potassium | 10 | 1986 | 279 | 0.090 |
Why?
|
| Complement C5a | 3 | 1997 | 23 | 0.090 |
Why?
|
| Hyaluronan Receptors | 1 | 2011 | 66 | 0.090 |
Why?
|
| Arrhythmias, Cardiac | 3 | 1986 | 457 | 0.090 |
Why?
|
| Histocytochemistry | 4 | 1999 | 106 | 0.090 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2011 | 132 | 0.090 |
Why?
|
| Electrocardiography | 10 | 2009 | 964 | 0.090 |
Why?
|
| Membrane Lipids | 3 | 1987 | 33 | 0.090 |
Why?
|
| Alprazolam | 1 | 1990 | 6 | 0.090 |
Why?
|
| Vascular Resistance | 5 | 2003 | 189 | 0.090 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2013 | 429 | 0.090 |
Why?
|
| Acidosis | 2 | 1988 | 92 | 0.090 |
Why?
|
| Aortic Valve Stenosis | 2 | 2005 | 322 | 0.090 |
Why?
|
| Receptors, Adrenergic | 4 | 1988 | 29 | 0.090 |
Why?
|
| Isoflurane | 2 | 2008 | 45 | 0.090 |
Why?
|
| Interleukin-13 | 1 | 2010 | 96 | 0.090 |
Why?
|
| Protein Array Analysis | 1 | 2010 | 101 | 0.090 |
Why?
|
| Antioxidants | 2 | 2018 | 338 | 0.090 |
Why?
|
| Species Specificity | 6 | 2006 | 552 | 0.090 |
Why?
|
| Nucleotides | 2 | 1989 | 92 | 0.090 |
Why?
|
| Cell Survival | 3 | 2019 | 817 | 0.090 |
Why?
|
| Hydrogen-Ion Concentration | 12 | 1988 | 424 | 0.090 |
Why?
|
| Blood Volume | 1 | 2010 | 79 | 0.090 |
Why?
|
| Platelet Membrane Glycoproteins | 3 | 1995 | 31 | 0.090 |
Why?
|
| Isoproterenol | 5 | 1985 | 105 | 0.090 |
Why?
|
| Solubility | 4 | 2002 | 133 | 0.090 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type II | 1 | 2009 | 12 | 0.090 |
Why?
|
| Amino Acids | 3 | 1983 | 661 | 0.080 |
Why?
|
| Embryonic Stem Cells | 1 | 2011 | 172 | 0.080 |
Why?
|
| Complement Activating Enzymes | 2 | 1989 | 3 | 0.080 |
Why?
|
| Models, Cardiovascular | 4 | 2011 | 170 | 0.080 |
Why?
|
| Ligation | 4 | 2003 | 134 | 0.080 |
Why?
|
| Sequence Homology, Amino Acid | 3 | 1995 | 658 | 0.080 |
Why?
|
| Substance Withdrawal Syndrome | 1 | 1990 | 140 | 0.080 |
Why?
|
| Cell- and Tissue-Based Therapy | 1 | 2011 | 155 | 0.080 |
Why?
|
| Cyclic GMP | 6 | 2005 | 92 | 0.080 |
Why?
|
| Leukocyte Rolling | 1 | 2009 | 4 | 0.080 |
Why?
|
| Receptors, CXCR6 | 3 | 2014 | 14 | 0.080 |
Why?
|
| Smad3 Protein | 1 | 2009 | 55 | 0.080 |
Why?
|
| Surface-Active Agents | 1 | 1989 | 31 | 0.080 |
Why?
|
| Serum Response Factor | 2 | 2012 | 30 | 0.080 |
Why?
|
| Ouabain | 5 | 1975 | 27 | 0.080 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2016 | 711 | 0.080 |
Why?
|
| Cardiovascular Abnormalities | 1 | 2009 | 51 | 0.080 |
Why?
|
| Lipid Metabolism | 2 | 2008 | 353 | 0.080 |
Why?
|
| Bradycardia | 2 | 1988 | 60 | 0.080 |
Why?
|
| Hemorheology | 2 | 2005 | 28 | 0.080 |
Why?
|
| Endorphins | 1 | 1988 | 7 | 0.080 |
Why?
|
| Serum Amyloid P-Component | 1 | 2008 | 13 | 0.080 |
Why?
|
| Phosphorylase b | 3 | 1983 | 6 | 0.080 |
Why?
|
| Histamine Release | 2 | 1998 | 10 | 0.080 |
Why?
|
| Lung Diseases, Interstitial | 1 | 2010 | 147 | 0.080 |
Why?
|
| Heart Block | 3 | 2004 | 41 | 0.080 |
Why?
|
| Actins | 6 | 2013 | 342 | 0.080 |
Why?
|
| Gene Expression Regulation, Enzymologic | 2 | 2006 | 262 | 0.080 |
Why?
|
| STAT1 Transcription Factor | 1 | 2008 | 69 | 0.080 |
Why?
|
| Ultrasonography | 5 | 2011 | 945 | 0.070 |
Why?
|
| CD11 Antigens | 3 | 1998 | 12 | 0.070 |
Why?
|
| Aged | 8 | 2021 | 18781 | 0.070 |
Why?
|
| Cell Membrane Permeability | 2 | 1986 | 74 | 0.070 |
Why?
|
| Alanine | 5 | 1983 | 181 | 0.070 |
Why?
|
| Systole | 4 | 2006 | 197 | 0.070 |
Why?
|
| Anesthetics | 2 | 2008 | 81 | 0.070 |
Why?
|
| Echocardiography | 5 | 2007 | 1067 | 0.070 |
Why?
|
| Binding Sites | 7 | 1995 | 1293 | 0.070 |
Why?
|
| Neutrophil Activation | 2 | 1999 | 16 | 0.070 |
Why?
|
| RNA Interference | 1 | 2009 | 497 | 0.070 |
Why?
|
| Microscopy, Electron | 9 | 1991 | 401 | 0.070 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 5 | 1991 | 314 | 0.070 |
Why?
|
| Body Weight | 3 | 2010 | 934 | 0.070 |
Why?
|
| NF-kappa B | 2 | 2013 | 462 | 0.070 |
Why?
|
| Perfusion | 4 | 1987 | 196 | 0.070 |
Why?
|
| Carbon Tetrachloride | 1 | 1986 | 7 | 0.070 |
Why?
|
| Glutamine | 5 | 1983 | 195 | 0.070 |
Why?
|
| Receptors, Platelet-Derived Growth Factor | 1 | 2006 | 19 | 0.070 |
Why?
|
| Platelet-Derived Growth Factor | 1 | 2006 | 42 | 0.070 |
Why?
|
| Calcium Signaling | 2 | 2021 | 241 | 0.070 |
Why?
|
| Membranes | 5 | 1987 | 23 | 0.070 |
Why?
|
| Serine Endopeptidases | 2 | 2005 | 174 | 0.070 |
Why?
|
| Phenobarbital | 1 | 1986 | 36 | 0.070 |
Why?
|
| Oxidative Stress | 4 | 2018 | 800 | 0.070 |
Why?
|
| Chimera | 1 | 2006 | 90 | 0.070 |
Why?
|
| Adenosine Triphosphatases | 15 | 1993 | 210 | 0.070 |
Why?
|
| Triglycerides | 2 | 2008 | 547 | 0.070 |
Why?
|
| Cell Membrane | 4 | 1986 | 459 | 0.070 |
Why?
|
| Antigens, CD34 | 1 | 2006 | 107 | 0.070 |
Why?
|
| Blood Glucose | 11 | 2008 | 1090 | 0.070 |
Why?
|
| Staining and Labeling | 3 | 2002 | 186 | 0.070 |
Why?
|
| Protein Kinases | 5 | 2003 | 330 | 0.070 |
Why?
|
| Amyloid | 1 | 2006 | 64 | 0.070 |
Why?
|
| Receptors, Oncostatin M | 1 | 2006 | 2 | 0.070 |
Why?
|
| Oncostatin M | 1 | 2006 | 6 | 0.070 |
Why?
|
| Receptors, Complement | 1 | 2006 | 32 | 0.070 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 2 | 2017 | 99 | 0.070 |
Why?
|
| Ibuprofen | 1 | 1986 | 41 | 0.070 |
Why?
|
| Chemokine CXCL1 | 1 | 2006 | 18 | 0.070 |
Why?
|
| Epinephrine | 6 | 1983 | 174 | 0.070 |
Why?
|
| Autophagy-Related Proteins | 1 | 2006 | 31 | 0.070 |
Why?
|
| Receptors, Cytokine | 1 | 2006 | 57 | 0.070 |
Why?
|
| NIH 3T3 Cells | 1 | 2006 | 92 | 0.070 |
Why?
|
| Epoprostenol | 1 | 1986 | 67 | 0.060 |
Why?
|
| Cofilin 1 | 2 | 2017 | 14 | 0.060 |
Why?
|
| Prognosis | 2 | 2014 | 4492 | 0.060 |
Why?
|
| Mitochondria | 4 | 2021 | 670 | 0.060 |
Why?
|
| Fibrin | 1 | 2006 | 67 | 0.060 |
Why?
|
| Adenine Nucleotides | 3 | 1970 | 41 | 0.060 |
Why?
|
| Cross-Sectional Studies | 1 | 2014 | 3306 | 0.060 |
Why?
|
| Seizures | 2 | 1990 | 875 | 0.060 |
Why?
|
| Atrial Natriuretic Factor | 1 | 2005 | 52 | 0.060 |
Why?
|
| Vasodilator Agents | 1 | 2007 | 203 | 0.060 |
Why?
|
| Potassium Compounds | 1 | 1985 | 9 | 0.060 |
Why?
|
| PPAR alpha | 1 | 2005 | 54 | 0.060 |
Why?
|
| Creatine Kinase | 1 | 1985 | 54 | 0.060 |
Why?
|
| Pindolol | 2 | 1983 | 7 | 0.060 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 2005 | 118 | 0.060 |
Why?
|
| Macrophage Inflammatory Proteins | 1 | 2004 | 13 | 0.060 |
Why?
|
| Chemokine CCL4 | 1 | 2004 | 16 | 0.060 |
Why?
|
| Egtazic Acid | 5 | 1986 | 25 | 0.060 |
Why?
|
| Monitoring, Physiologic | 2 | 2002 | 355 | 0.060 |
Why?
|
| Chemokines, CC | 1 | 2004 | 28 | 0.060 |
Why?
|
| Recombinant Proteins | 3 | 1998 | 1402 | 0.060 |
Why?
|
| Motion | 1 | 2004 | 44 | 0.060 |
Why?
|
| DNA, Complementary | 2 | 1995 | 465 | 0.060 |
Why?
|
| Phosphatidylinositol 3-Kinases | 2 | 2004 | 343 | 0.060 |
Why?
|
| Rats, Sprague-Dawley | 4 | 2013 | 1214 | 0.060 |
Why?
|
| Guanine Nucleotide Dissociation Inhibitors | 1 | 2004 | 10 | 0.060 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2006 | 282 | 0.060 |
Why?
|
| Atrioventricular Node | 1 | 2004 | 16 | 0.060 |
Why?
|
| Cell Communication | 2 | 2017 | 165 | 0.060 |
Why?
|
| Chagas Cardiomyopathy | 1 | 2004 | 45 | 0.060 |
Why?
|
| Adaptation, Physiological | 4 | 2009 | 265 | 0.060 |
Why?
|
| Body Temperature | 1 | 2004 | 103 | 0.060 |
Why?
|
| Electrophysiologic Techniques, Cardiac | 1 | 2004 | 58 | 0.060 |
Why?
|
| Aldosterone | 1 | 2004 | 59 | 0.060 |
Why?
|
| Xanthine Oxidase | 2 | 1994 | 16 | 0.060 |
Why?
|
| Predictive Value of Tests | 2 | 2015 | 2078 | 0.060 |
Why?
|
| Free Radicals | 2 | 1994 | 31 | 0.060 |
Why?
|
| Myoblasts, Cardiac | 1 | 2003 | 7 | 0.060 |
Why?
|
| Acute Kidney Injury | 1 | 2011 | 606 | 0.060 |
Why?
|
| Adenylyl Cyclases | 8 | 1985 | 75 | 0.060 |
Why?
|
| Glutathione | 3 | 2018 | 198 | 0.060 |
Why?
|
| Polyethylene Glycols | 3 | 1991 | 217 | 0.060 |
Why?
|
| Sialoglycoproteins | 2 | 2005 | 48 | 0.060 |
Why?
|
| Hydrolysis | 4 | 1991 | 156 | 0.060 |
Why?
|
| Cardiac Pacing, Artificial | 1 | 2004 | 112 | 0.060 |
Why?
|
| Myofibrils | 2 | 1980 | 27 | 0.060 |
Why?
|
| Prospective Studies | 1 | 2014 | 5974 | 0.050 |
Why?
|
| Receptor, Macrophage Colony-Stimulating Factor | 1 | 2003 | 5 | 0.050 |
Why?
|
| Multivariate Analysis | 2 | 2002 | 1403 | 0.050 |
Why?
|
| Osteopontin | 2 | 2005 | 49 | 0.050 |
Why?
|
| Muscle Denervation | 1 | 1983 | 7 | 0.050 |
Why?
|
| Cell Size | 3 | 2013 | 81 | 0.050 |
Why?
|
| Radioisotopes | 3 | 1999 | 38 | 0.050 |
Why?
|
| Ultrasonography, Doppler, Pulsed | 1 | 2003 | 25 | 0.050 |
Why?
|
| Neovascularization, Physiologic | 4 | 2006 | 210 | 0.050 |
Why?
|
| Calcium Channels, L-Type | 1 | 2003 | 53 | 0.050 |
Why?
|
| Calcium Channel Blockers | 1 | 2003 | 113 | 0.050 |
Why?
|
| Ventricular Function, Right | 1 | 2004 | 112 | 0.050 |
Why?
|
| Calcimycin | 3 | 1989 | 26 | 0.050 |
Why?
|
| Oxidation-Reduction | 4 | 1992 | 444 | 0.050 |
Why?
|
| Growth Inhibitors | 1 | 2002 | 39 | 0.050 |
Why?
|
| Lipopolysaccharides | 3 | 2011 | 292 | 0.050 |
Why?
|
| Ischemia | 3 | 2003 | 342 | 0.050 |
Why?
|
| Lymphokines | 1 | 2002 | 66 | 0.050 |
Why?
|
| Carnitine | 3 | 1979 | 78 | 0.050 |
Why?
|
| In Situ Nick-End Labeling | 2 | 2002 | 123 | 0.050 |
Why?
|
| Zinc Finger Protein GLI1 | 1 | 2022 | 37 | 0.050 |
Why?
|
| Blood Pressure Determination | 1 | 2003 | 105 | 0.050 |
Why?
|
| Graft Rejection | 2 | 1997 | 580 | 0.050 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 1 | 2002 | 63 | 0.050 |
Why?
|
| Constriction | 3 | 2009 | 49 | 0.050 |
Why?
|
| Tenascin | 1 | 2002 | 35 | 0.050 |
Why?
|
| Atherosclerosis | 1 | 2010 | 828 | 0.050 |
Why?
|
| Hormones | 1 | 2003 | 189 | 0.050 |
Why?
|
| Carbachol | 2 | 1978 | 18 | 0.050 |
Why?
|
| Rheology | 2 | 1995 | 31 | 0.050 |
Why?
|
| Captopril | 1 | 2002 | 28 | 0.050 |
Why?
|
| Plant Lectins | 1 | 2002 | 5 | 0.050 |
Why?
|
| Pancuronium | 1 | 1982 | 7 | 0.050 |
Why?
|
| Cell-Free System | 2 | 2000 | 106 | 0.050 |
Why?
|
| Neural Cell Adhesion Molecules | 1 | 2002 | 17 | 0.050 |
Why?
|
| Palmitoylcarnitine | 2 | 1979 | 6 | 0.050 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2003 | 213 | 0.050 |
Why?
|
| Heart Septum | 1 | 2002 | 57 | 0.050 |
Why?
|
| Ribose | 1 | 2021 | 11 | 0.050 |
Why?
|
| Neutrophil Infiltration | 1 | 2002 | 65 | 0.050 |
Why?
|
| Telomere | 1 | 2003 | 205 | 0.050 |
Why?
|
| Fluorescein-5-isothiocyanate | 2 | 1991 | 30 | 0.050 |
Why?
|
| Adenosine Diphosphate | 1 | 2021 | 58 | 0.050 |
Why?
|
| Kv1.5 Potassium Channel | 1 | 2021 | 8 | 0.050 |
Why?
|
| Peroxisome Proliferator-Activated Receptors | 2 | 2013 | 13 | 0.050 |
Why?
|
| Poly (ADP-Ribose) Polymerase-1 | 1 | 2021 | 21 | 0.050 |
Why?
|
| Microspheres | 1 | 1981 | 70 | 0.050 |
Why?
|
| Sheep, Domestic | 1 | 2021 | 17 | 0.050 |
Why?
|
| Liver Circulation | 5 | 1986 | 24 | 0.050 |
Why?
|
| Phosphorylase Kinase | 3 | 1977 | 6 | 0.050 |
Why?
|
| Organ Size | 3 | 2010 | 410 | 0.050 |
Why?
|
| Bone Marrow Transplantation | 2 | 2014 | 581 | 0.050 |
Why?
|
| Organophosphorus Compounds | 1 | 1981 | 23 | 0.050 |
Why?
|
| Troponin T | 2 | 2004 | 245 | 0.050 |
Why?
|
| Erythrocytes | 2 | 1995 | 207 | 0.050 |
Why?
|
| Acceleration | 1 | 2021 | 26 | 0.050 |
Why?
|
| Genetic Therapy | 1 | 2005 | 707 | 0.050 |
Why?
|
| Muscle, Skeletal | 2 | 1997 | 927 | 0.050 |
Why?
|
| Bucladesine | 1 | 1980 | 19 | 0.050 |
Why?
|
| Dobutamine | 1 | 2021 | 56 | 0.050 |
Why?
|
| Mitral Valve | 2 | 2008 | 245 | 0.050 |
Why?
|
| Cell Death | 2 | 1998 | 242 | 0.050 |
Why?
|
| Endotoxins | 1 | 2000 | 50 | 0.050 |
Why?
|
| Tissue Distribution | 2 | 2006 | 382 | 0.050 |
Why?
|
| Chemokine CXCL10 | 1 | 2000 | 54 | 0.050 |
Why?
|
| Glycoproteins | 1 | 2003 | 371 | 0.050 |
Why?
|
| Feedback | 1 | 2021 | 160 | 0.040 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 2000 | 287 | 0.040 |
Why?
|
| Endothelium | 1 | 2000 | 73 | 0.040 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2002 | 210 | 0.040 |
Why?
|
| Structure-Activity Relationship | 2 | 2019 | 565 | 0.040 |
Why?
|
| Proteins | 1 | 2006 | 1041 | 0.040 |
Why?
|
| Precipitin Tests | 1 | 2000 | 153 | 0.040 |
Why?
|
| Thrombosis | 2 | 2013 | 517 | 0.040 |
Why?
|
| Substrate Specificity | 2 | 1991 | 284 | 0.040 |
Why?
|
| Transcription, Genetic | 3 | 2006 | 1703 | 0.040 |
Why?
|
| Subcellular Fractions | 2 | 1993 | 98 | 0.040 |
Why?
|
| Receptors, Fibronectin | 1 | 1999 | 8 | 0.040 |
Why?
|
| Oxygen | 2 | 2003 | 548 | 0.040 |
Why?
|
| Enzymes | 2 | 1970 | 51 | 0.040 |
Why?
|
| Genes, Reporter | 4 | 2003 | 385 | 0.040 |
Why?
|
| Microscopy, Electron, Scanning Transmission | 1 | 1999 | 7 | 0.040 |
Why?
|
| Aortic Valve | 2 | 2008 | 426 | 0.040 |
Why?
|
| Membrane Glycoproteins | 1 | 2002 | 414 | 0.040 |
Why?
|
| RNA | 1 | 2003 | 577 | 0.040 |
Why?
|
| Diet | 1 | 2006 | 1091 | 0.040 |
Why?
|
| Tritium | 4 | 1993 | 174 | 0.040 |
Why?
|
| Water | 1 | 1980 | 180 | 0.040 |
Why?
|
| Lactones | 2 | 1969 | 32 | 0.040 |
Why?
|
| Fibronectins | 1 | 1999 | 104 | 0.040 |
Why?
|
| Tantalum | 1 | 1999 | 7 | 0.040 |
Why?
|
| Mice, Inbred Strains | 4 | 2003 | 317 | 0.040 |
Why?
|
| Muscle, Smooth | 3 | 2004 | 137 | 0.040 |
Why?
|
| Neostigmine | 1 | 1978 | 6 | 0.040 |
Why?
|
| Cardiovascular Diseases | 1 | 2011 | 1803 | 0.040 |
Why?
|
| DNA Fragmentation | 1 | 1998 | 53 | 0.040 |
Why?
|
| CD5 Antigens | 1 | 1998 | 37 | 0.040 |
Why?
|
| Action Potentials | 2 | 2021 | 499 | 0.040 |
Why?
|
| DNA Primers | 2 | 2003 | 669 | 0.040 |
Why?
|
| Proliferating Cell Nuclear Antigen | 1 | 1998 | 38 | 0.040 |
Why?
|
| Microtubules | 2 | 1979 | 196 | 0.040 |
Why?
|
| Acetylcholine | 1 | 1978 | 83 | 0.040 |
Why?
|
| Epithelial Cells | 1 | 2003 | 907 | 0.040 |
Why?
|
| Factor VIII | 1 | 1998 | 45 | 0.040 |
Why?
|
| Ethanolamines | 3 | 1969 | 30 | 0.040 |
Why?
|
| Electric Stimulation | 2 | 2004 | 320 | 0.040 |
Why?
|
| Magnesium | 4 | 1989 | 121 | 0.040 |
Why?
|
| Oxalic Acid | 2 | 1991 | 10 | 0.040 |
Why?
|
| Brain | 1 | 1990 | 2948 | 0.040 |
Why?
|
| Anions | 2 | 1991 | 18 | 0.040 |
Why?
|
| Transplantation, Homologous | 2 | 1997 | 659 | 0.040 |
Why?
|
| Cell Fractionation | 5 | 1980 | 38 | 0.040 |
Why?
|
| Angiogenesis Inducing Agents | 1 | 2017 | 21 | 0.040 |
Why?
|
| Mersalyl | 2 | 1989 | 3 | 0.040 |
Why?
|
| Taurine | 1 | 1977 | 12 | 0.040 |
Why?
|
| Tight Junctions | 1 | 1997 | 37 | 0.040 |
Why?
|
| Deoxycholic Acid | 1 | 1977 | 13 | 0.040 |
Why?
|
| Pressure | 2 | 2006 | 128 | 0.040 |
Why?
|
| Models, Animal | 2 | 2011 | 466 | 0.040 |
Why?
|
| Paracrine Communication | 1 | 2017 | 71 | 0.040 |
Why?
|
| Serotonin | 3 | 1983 | 221 | 0.040 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2017 | 112 | 0.040 |
Why?
|
| Lasalocid | 3 | 1982 | 6 | 0.040 |
Why?
|
| Macrophage Activation | 1 | 2017 | 63 | 0.040 |
Why?
|
| Cellular Senescence | 1 | 2018 | 158 | 0.040 |
Why?
|
| Cell Transplantation | 1 | 1997 | 54 | 0.040 |
Why?
|
| Cloning, Molecular | 1 | 1998 | 900 | 0.030 |
Why?
|
| Oxygen Consumption | 7 | 1985 | 304 | 0.030 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2019 | 192 | 0.030 |
Why?
|
| Survival Rate | 1 | 2002 | 2001 | 0.030 |
Why?
|
| Equipment Design | 2 | 2011 | 598 | 0.030 |
Why?
|
| Veins | 1 | 1997 | 106 | 0.030 |
Why?
|
| Mitral Valve Stenosis | 1 | 1976 | 34 | 0.030 |
Why?
|
| Lipid Bilayers | 2 | 1987 | 46 | 0.030 |
Why?
|
| ras-GRF1 | 1 | 2015 | 1 | 0.030 |
Why?
|
| Thyroxine | 1 | 1996 | 65 | 0.030 |
Why?
|
| Chymases | 2 | 2008 | 6 | 0.030 |
Why?
|
| Mammals | 1 | 1997 | 263 | 0.030 |
Why?
|
| Alkyl and Aryl Transferases | 1 | 2015 | 18 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2019 | 1677 | 0.030 |
Why?
|
| Gene Expression Profiling | 3 | 2009 | 1674 | 0.030 |
Why?
|
| Thyroid Hormone Receptors alpha | 1 | 2015 | 14 | 0.030 |
Why?
|
| Catecholamines | 2 | 1979 | 58 | 0.030 |
Why?
|
| Regression Analysis | 1 | 1997 | 750 | 0.030 |
Why?
|
| Stem Cell Transplantation | 1 | 1997 | 239 | 0.030 |
Why?
|
| Hydroxylation | 1 | 2015 | 45 | 0.030 |
Why?
|
| Cadherins | 2 | 2008 | 164 | 0.030 |
Why?
|
| DNA Probes | 1 | 1995 | 125 | 0.030 |
Why?
|
| Nuclear Receptor Co-Repressor 2 | 1 | 2015 | 37 | 0.030 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2017 | 414 | 0.030 |
Why?
|
| Homeostasis | 3 | 2012 | 680 | 0.030 |
Why?
|
| Cell Migration Assays | 1 | 2014 | 2 | 0.030 |
Why?
|
| Down-Regulation | 2 | 2009 | 701 | 0.030 |
Why?
|
| Rhinovirus | 1 | 1995 | 59 | 0.030 |
Why?
|
| Xanthine | 1 | 1994 | 8 | 0.030 |
Why?
|
| Xanthines | 1 | 1994 | 14 | 0.030 |
Why?
|
| Picornaviridae Infections | 1 | 1995 | 48 | 0.030 |
Why?
|
| Fourier Analysis | 1 | 1995 | 61 | 0.030 |
Why?
|
| Cytoplasm | 2 | 1993 | 290 | 0.030 |
Why?
|
| Caspase 3 | 2 | 2006 | 130 | 0.030 |
Why?
|
| Phospholipases | 1 | 1994 | 7 | 0.030 |
Why?
|
| HEK293 Cells | 1 | 2017 | 742 | 0.030 |
Why?
|
| Microscopy, Immunoelectron | 1 | 1994 | 26 | 0.030 |
Why?
|
| Hypoglycemic Agents | 1 | 2018 | 411 | 0.030 |
Why?
|
| Cell Aggregation | 2 | 1994 | 23 | 0.030 |
Why?
|
| Vena Cava, Superior | 1 | 1995 | 55 | 0.030 |
Why?
|
| Macrophages, Alveolar | 1 | 1994 | 44 | 0.030 |
Why?
|
| Malaria | 1 | 1995 | 82 | 0.030 |
Why?
|
| Conserved Sequence | 1 | 1995 | 293 | 0.030 |
Why?
|
| Gene Library | 1 | 1995 | 220 | 0.030 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 1 | 2015 | 168 | 0.030 |
Why?
|
| Lim Kinases | 1 | 2013 | 9 | 0.030 |
Why?
|
| Heart Conduction System | 4 | 2004 | 146 | 0.030 |
Why?
|
| Acute Disease | 2 | 1996 | 1092 | 0.030 |
Why?
|
| Histocompatibility Testing | 1 | 1994 | 147 | 0.030 |
Why?
|
| Albuminuria | 1 | 2014 | 91 | 0.030 |
Why?
|
| Tryptases | 2 | 2005 | 20 | 0.030 |
Why?
|
| Calcium Radioisotopes | 1 | 1993 | 2 | 0.030 |
Why?
|
| Ryanodine | 1 | 1993 | 7 | 0.030 |
Why?
|
| Physical Endurance | 1 | 1993 | 43 | 0.030 |
Why?
|
| Cesium | 1 | 1993 | 13 | 0.030 |
Why?
|
| Isomerism | 1 | 1993 | 31 | 0.030 |
Why?
|
| Thrombin | 1 | 2013 | 60 | 0.030 |
Why?
|
| Amides | 1 | 2013 | 82 | 0.030 |
Why?
|
| Luciferases | 1 | 2013 | 137 | 0.030 |
Why?
|
| Arterioles | 2 | 2004 | 27 | 0.030 |
Why?
|
| Sirtuin 1 | 1 | 2013 | 48 | 0.030 |
Why?
|
| Ventricular Function | 2 | 2004 | 93 | 0.030 |
Why?
|
| L-Selectin | 1 | 1993 | 21 | 0.030 |
Why?
|
| Antigens, Differentiation | 2 | 1990 | 63 | 0.030 |
Why?
|
| Membrane Potentials | 2 | 1993 | 304 | 0.030 |
Why?
|
| Shock, Hemorrhagic | 3 | 1969 | 50 | 0.030 |
Why?
|
| Transendothelial and Transepithelial Migration | 1 | 2013 | 9 | 0.030 |
Why?
|
| Immunoblotting | 1 | 2013 | 312 | 0.030 |
Why?
|
| HLA Antigens | 1 | 1994 | 242 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2002 | 3306 | 0.030 |
Why?
|
| Cytochrome c Group | 1 | 1992 | 16 | 0.030 |
Why?
|
| Antibodies | 1 | 1994 | 371 | 0.030 |
Why?
|
| Cats | 4 | 1997 | 115 | 0.030 |
Why?
|
| Respiratory Muscles | 1 | 1992 | 8 | 0.030 |
Why?
|
| Dietary Fats, Unsaturated | 1 | 1993 | 33 | 0.030 |
Why?
|
| Respiratory Burst | 1 | 1992 | 10 | 0.030 |
Why?
|
| Microarray Analysis | 1 | 2013 | 231 | 0.030 |
Why?
|
| Mice, 129 Strain | 1 | 2013 | 100 | 0.030 |
Why?
|
| Integrins | 3 | 2003 | 81 | 0.030 |
Why?
|
| Sequence Alignment | 1 | 1994 | 623 | 0.030 |
Why?
|
| Ion Channel Gating | 1 | 1993 | 123 | 0.030 |
Why?
|
| Ions | 1 | 1972 | 23 | 0.030 |
Why?
|
| Statistics, Nonparametric | 1 | 2013 | 420 | 0.030 |
Why?
|
| Atropine | 4 | 1985 | 30 | 0.030 |
Why?
|
| Th2 Cells | 1 | 2013 | 187 | 0.030 |
Why?
|
| Arterial Pressure | 1 | 2013 | 104 | 0.030 |
Why?
|
| Sarcoplasmic Reticulum Calcium-Transporting ATPases | 1 | 2012 | 37 | 0.030 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2013 | 127 | 0.030 |
Why?
|
| Coculture Techniques | 1 | 2013 | 234 | 0.030 |
Why?
|
| Pyridines | 1 | 2013 | 222 | 0.030 |
Why?
|
| Cell Line | 2 | 2013 | 2785 | 0.030 |
Why?
|
| Affinity Labels | 1 | 1991 | 14 | 0.020 |
Why?
|
| Phentolamine | 2 | 1988 | 20 | 0.020 |
Why?
|
| Photochemistry | 1 | 1991 | 22 | 0.020 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 1 | 1991 | 42 | 0.020 |
Why?
|
| Technetium | 1 | 1991 | 13 | 0.020 |
Why?
|
| Papillary Muscles | 4 | 1985 | 19 | 0.020 |
Why?
|
| Phospholipases A | 3 | 1987 | 39 | 0.020 |
Why?
|
| Cell Degranulation | 2 | 2005 | 29 | 0.020 |
Why?
|
| Transducers, Pressure | 1 | 2011 | 13 | 0.020 |
Why?
|
| Microscopy, Electron, Scanning | 3 | 1999 | 152 | 0.020 |
Why?
|
| Miniaturization | 1 | 2011 | 27 | 0.020 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2013 | 516 | 0.020 |
Why?
|
| Radionuclide Imaging | 1 | 1991 | 151 | 0.020 |
Why?
|
| Protein Conformation | 1 | 1993 | 835 | 0.020 |
Why?
|
| Nanofibers | 1 | 2011 | 15 | 0.020 |
Why?
|
| Ryanodine Receptor Calcium Release Channel | 1 | 1993 | 232 | 0.020 |
Why?
|
| Leukocyte Count | 2 | 1996 | 245 | 0.020 |
Why?
|
| Epigenesis, Genetic | 1 | 2015 | 665 | 0.020 |
Why?
|
| Cardiac Output | 5 | 1981 | 169 | 0.020 |
Why?
|
| Hypertrophy | 2 | 2004 | 99 | 0.020 |
Why?
|
| Lymphatic System | 2 | 1981 | 20 | 0.020 |
Why?
|
| Transgenes | 2 | 2004 | 336 | 0.020 |
Why?
|
| Proteinuria | 1 | 2011 | 110 | 0.020 |
Why?
|
| Metoprolol | 1 | 1990 | 22 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2015 | 2012 | 0.020 |
Why?
|
| Adult | 8 | 2006 | 28746 | 0.020 |
Why?
|
| Syndrome | 1 | 1993 | 1122 | 0.020 |
Why?
|
| Carbon Dioxide | 4 | 1988 | 274 | 0.020 |
Why?
|
| Biological Transport | 4 | 1972 | 347 | 0.020 |
Why?
|
| Brain Chemistry | 2 | 1987 | 121 | 0.020 |
Why?
|
| Gene Deletion | 1 | 2013 | 798 | 0.020 |
Why?
|
| Injections, Intraventricular | 1 | 1990 | 65 | 0.020 |
Why?
|
| Ion Channels | 1 | 1991 | 187 | 0.020 |
Why?
|
| Rats, Inbred Strains | 2 | 1987 | 227 | 0.020 |
Why?
|
| Fluorescent Dyes | 1 | 1991 | 261 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 2 | 2004 | 1354 | 0.020 |
Why?
|
| Heart Function Tests | 2 | 2009 | 57 | 0.020 |
Why?
|
| Weight-Bearing | 1 | 2010 | 44 | 0.020 |
Why?
|
| Receptors, Estrogen | 1 | 2013 | 788 | 0.020 |
Why?
|
| Immunoenzyme Techniques | 1 | 1990 | 268 | 0.020 |
Why?
|
| Recovery of Function | 2 | 2002 | 433 | 0.020 |
Why?
|
| Glutathione Peroxidase | 2 | 2006 | 32 | 0.020 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2014 | 541 | 0.020 |
Why?
|
| Platelet Activating Factor | 3 | 1996 | 29 | 0.020 |
Why?
|
| Glutamates | 2 | 1980 | 69 | 0.020 |
Why?
|
| Tachycardia | 3 | 1986 | 67 | 0.020 |
Why?
|
| Lipid Peroxidation | 1 | 1989 | 83 | 0.020 |
Why?
|
| Vanadates | 1 | 1989 | 12 | 0.020 |
Why?
|
| Complement C1q | 2 | 1989 | 19 | 0.020 |
Why?
|
| Lanthanum | 1 | 1969 | 4 | 0.020 |
Why?
|
| Molecular Weight | 4 | 1989 | 393 | 0.020 |
Why?
|
| Complement Pathway, Classical | 1 | 1989 | 5 | 0.020 |
Why?
|
| Adenylyl Cyclase Inhibitors | 3 | 1977 | 9 | 0.020 |
Why?
|
| Reaction Time | 1 | 1990 | 170 | 0.020 |
Why?
|
| Biomechanical Phenomena | 1 | 1990 | 237 | 0.020 |
Why?
|
| Hypotension | 2 | 1968 | 177 | 0.020 |
Why?
|
| Guanylyl Imidodiphosphate | 2 | 1985 | 3 | 0.020 |
Why?
|
| Biomedical Engineering | 1 | 2009 | 30 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 1 | 1995 | 1759 | 0.020 |
Why?
|
| Acid-Base Equilibrium | 1 | 1988 | 59 | 0.020 |
Why?
|
| Mice, Obese | 1 | 2008 | 77 | 0.020 |
Why?
|
| Phospholipases A2 | 2 | 1987 | 35 | 0.020 |
Why?
|
| Hydrochloric Acid | 1 | 1988 | 14 | 0.020 |
Why?
|
| Asphyxia Neonatorum | 1 | 1988 | 15 | 0.020 |
Why?
|
| Lung | 1 | 1996 | 1487 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 3 | 1997 | 1009 | 0.020 |
Why?
|
| Bacillus | 1 | 1968 | 33 | 0.020 |
Why?
|
| Naloxone | 1 | 1988 | 46 | 0.020 |
Why?
|
| Hyperemia | 1 | 2008 | 25 | 0.020 |
Why?
|
| Immunosuppressive Agents | 3 | 1997 | 646 | 0.020 |
Why?
|
| Coronary Stenosis | 1 | 2009 | 70 | 0.020 |
Why?
|
| Oxidative Phosphorylation | 5 | 1980 | 93 | 0.020 |
Why?
|
| Glucose Tolerance Test | 1 | 1988 | 202 | 0.020 |
Why?
|
| Sheep | 1 | 1988 | 211 | 0.020 |
Why?
|
| Osmolar Concentration | 2 | 1983 | 173 | 0.020 |
Why?
|
| Aniline Compounds | 1 | 1967 | 19 | 0.020 |
Why?
|
| Stress, Mechanical | 2 | 1999 | 171 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2010 | 747 | 0.020 |
Why?
|
| Frontal Lobe | 1 | 1987 | 109 | 0.020 |
Why?
|
| Mathematics | 2 | 1985 | 97 | 0.020 |
Why?
|
| beta-Galactosidase | 2 | 1997 | 157 | 0.020 |
Why?
|
| Octoxynol | 1 | 1986 | 7 | 0.020 |
Why?
|
| Receptors, Serotonin | 2 | 1983 | 42 | 0.020 |
Why?
|
| Environment | 1 | 1987 | 135 | 0.020 |
Why?
|
| Membrane Fluidity | 1 | 1987 | 18 | 0.020 |
Why?
|
| GTP-Binding Proteins | 1 | 1987 | 174 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-sis | 1 | 2006 | 19 | 0.020 |
Why?
|
| Receptor, Platelet-Derived Growth Factor alpha | 1 | 2006 | 22 | 0.020 |
Why?
|
| Pancreatectomy | 2 | 1984 | 135 | 0.020 |
Why?
|
| Dwarfism | 1 | 2007 | 102 | 0.020 |
Why?
|
| 4-Nitrophenylphosphatase | 1 | 1986 | 3 | 0.020 |
Why?
|
| Tacrolimus | 2 | 1997 | 99 | 0.020 |
Why?
|
| Exercise Test | 1 | 2007 | 245 | 0.020 |
Why?
|
| Ceramides | 1 | 2006 | 38 | 0.020 |
Why?
|
| Protein Carbonylation | 1 | 2006 | 7 | 0.020 |
Why?
|
| Blood Vessels | 1 | 2006 | 102 | 0.020 |
Why?
|
| Cardiac Complexes, Premature | 1 | 1986 | 6 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2009 | 1000 | 0.020 |
Why?
|
| Consciousness | 2 | 1983 | 49 | 0.020 |
Why?
|
| Platelet Count | 1 | 1986 | 130 | 0.020 |
Why?
|
| Adrenergic alpha-Antagonists | 1 | 1986 | 46 | 0.020 |
Why?
|
| Heme Oxygenase-1 | 1 | 2006 | 34 | 0.020 |
Why?
|
| Clathrin | 1 | 1986 | 24 | 0.020 |
Why?
|
| Collateral Circulation | 1 | 1986 | 45 | 0.020 |
Why?
|
| Adenylyl Imidodiphosphate | 1 | 1985 | 2 | 0.020 |
Why?
|
| Ethylmaleimide | 1 | 1985 | 13 | 0.020 |
Why?
|
| Demography | 1 | 2006 | 237 | 0.020 |
Why?
|
| Gastric Inhibitory Polypeptide | 1 | 1985 | 19 | 0.020 |
Why?
|
| Guanine Nucleotides | 1 | 1985 | 15 | 0.020 |
Why?
|
| Receptors, Muscarinic | 1 | 1985 | 15 | 0.020 |
Why?
|
| Equipment Failure Analysis | 1 | 2005 | 89 | 0.020 |
Why?
|
| Mifepristone | 1 | 2005 | 138 | 0.020 |
Why?
|
| Glucan 1,4-alpha-Glucosidase | 1 | 1985 | 5 | 0.020 |
Why?
|
| Ionophores | 1 | 1985 | 8 | 0.020 |
Why?
|
| Dexamethasone | 1 | 1986 | 274 | 0.020 |
Why?
|
| Serum Albumin | 1 | 1985 | 107 | 0.020 |
Why?
|
| Neutrons | 1 | 1984 | 9 | 0.020 |
Why?
|
| Chemistry | 1 | 1984 | 59 | 0.020 |
Why?
|
| Chromatography, Thin Layer | 1 | 1984 | 41 | 0.020 |
Why?
|
| Chemical Phenomena | 1 | 1984 | 84 | 0.020 |
Why?
|
| Guinea Pigs | 2 | 1989 | 169 | 0.010 |
Why?
|
| Binding, Competitive | 2 | 1983 | 179 | 0.010 |
Why?
|
| X-Ray Diffraction | 1 | 1984 | 95 | 0.010 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2006 | 270 | 0.010 |
Why?
|
| Granuloma | 1 | 2005 | 69 | 0.010 |
Why?
|
| Animals, Newborn | 1 | 1988 | 1007 | 0.010 |
Why?
|
| Phosphates | 2 | 1979 | 112 | 0.010 |
Why?
|
| Pneumonia | 1 | 1968 | 325 | 0.010 |
Why?
|
| rho-Specific Guanine Nucleotide Dissociation Inhibitors | 1 | 2004 | 8 | 0.010 |
Why?
|
| Cytochrome P-450 CYP11B2 | 1 | 2004 | 5 | 0.010 |
Why?
|
| rho Guanine Nucleotide Dissociation Inhibitor alpha | 1 | 2004 | 10 | 0.010 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 1986 | 233 | 0.010 |
Why?
|
| Connexin 43 | 1 | 2004 | 30 | 0.010 |
Why?
|
| Acyltransferases | 2 | 1979 | 46 | 0.010 |
Why?
|
| Spectrophotometry | 3 | 1972 | 59 | 0.010 |
Why?
|
| Spironolactone | 1 | 2004 | 18 | 0.010 |
Why?
|
| Muscle Cells | 1 | 2004 | 23 | 0.010 |
Why?
|
| NF-KappaB Inhibitor alpha | 1 | 2003 | 34 | 0.010 |
Why?
|
| Sympatholytics | 1 | 1983 | 4 | 0.010 |
Why?
|
| Cytoprotection | 1 | 2003 | 39 | 0.010 |
Why?
|
| Connexins | 1 | 2004 | 56 | 0.010 |
Why?
|
| Lysergic Acid Diethylamide | 1 | 1983 | 6 | 0.010 |
Why?
|
| Pancreatic Polypeptide | 1 | 1983 | 7 | 0.010 |
Why?
|
| I-kappa B Proteins | 1 | 2003 | 41 | 0.010 |
Why?
|
| 4-Acetamido-4'-isothiocyanatostilbene-2,2'-disulfonic Acid | 1 | 1983 | 3 | 0.010 |
Why?
|
| Ultrasonics | 1 | 1983 | 36 | 0.010 |
Why?
|
| 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid | 1 | 1983 | 4 | 0.010 |
Why?
|
| Serotonin Antagonists | 1 | 1983 | 24 | 0.010 |
Why?
|
| Portal Vein | 4 | 1985 | 92 | 0.010 |
Why?
|
| Succinic Acid | 1 | 1983 | 14 | 0.010 |
Why?
|
| Succinates | 1 | 1983 | 20 | 0.010 |
Why?
|
| DNA-Binding Proteins | 1 | 2012 | 2041 | 0.010 |
Why?
|
| Cell Fusion | 1 | 2003 | 43 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2006 | 493 | 0.010 |
Why?
|
| N-Formylmethionine Leucyl-Phenylalanine | 2 | 1996 | 12 | 0.010 |
Why?
|
| Stimulation, Chemical | 3 | 1975 | 64 | 0.010 |
Why?
|
| Organ Specificity | 2 | 2002 | 428 | 0.010 |
Why?
|
| Mutation | 1 | 2017 | 5786 | 0.010 |
Why?
|
| Models, Genetic | 1 | 2006 | 748 | 0.010 |
Why?
|
| Myoblasts | 1 | 2003 | 30 | 0.010 |
Why?
|
| Nucleoside-Triphosphatase | 1 | 1983 | 3 | 0.010 |
Why?
|
| Nimodipine | 1 | 2003 | 7 | 0.010 |
Why?
|
| rho GTP-Binding Proteins | 1 | 2004 | 68 | 0.010 |
Why?
|
| Administration, Oral | 4 | 1986 | 668 | 0.010 |
Why?
|
| Checkpoint Kinase 2 | 1 | 2003 | 33 | 0.010 |
Why?
|
| Tail | 1 | 2003 | 16 | 0.010 |
Why?
|
| 3',5'-Cyclic-AMP Phosphodiesterases | 2 | 1980 | 22 | 0.010 |
Why?
|
| Telomerase | 1 | 2004 | 165 | 0.010 |
Why?
|
| Protein Isoforms | 1 | 2004 | 410 | 0.010 |
Why?
|
| Elasticity | 1 | 2003 | 92 | 0.010 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 1984 | 139 | 0.010 |
Why?
|
| Spectrometry, Fluorescence | 1 | 2003 | 87 | 0.010 |
Why?
|
| Freeze Fracturing | 1 | 1982 | 2 | 0.010 |
Why?
|
| Cattle | 1 | 2004 | 559 | 0.010 |
Why?
|
| Leukemia Inhibitory Factor | 1 | 2002 | 26 | 0.010 |
Why?
|
| Prostaglandins | 1 | 1982 | 48 | 0.010 |
Why?
|
| Dilatation, Pathologic | 1 | 2003 | 93 | 0.010 |
Why?
|
| Matrix Metalloproteinases | 1 | 2003 | 65 | 0.010 |
Why?
|
| Remission Induction | 1 | 2003 | 301 | 0.010 |
Why?
|
| Micropore Filters | 2 | 1972 | 7 | 0.010 |
Why?
|
| beta Catenin | 1 | 2004 | 208 | 0.010 |
Why?
|
| Genes | 1 | 2003 | 443 | 0.010 |
Why?
|
| Cytoskeletal Proteins | 1 | 2004 | 270 | 0.010 |
Why?
|
| Nonmuscle Myosin Type IIB | 1 | 2002 | 3 | 0.010 |
Why?
|
| Chickens | 1 | 1983 | 637 | 0.010 |
Why?
|
| Adenoviridae | 1 | 2005 | 637 | 0.010 |
Why?
|
| Artificial Intelligence | 1 | 2005 | 228 | 0.010 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2002 | 94 | 0.010 |
Why?
|
| Muscular Atrophy | 1 | 1983 | 75 | 0.010 |
Why?
|
| CD146 Antigen | 1 | 2002 | 7 | 0.010 |
Why?
|
| Arterial Occlusive Diseases | 1 | 1983 | 127 | 0.010 |
Why?
|
| Sodium | 5 | 1976 | 290 | 0.010 |
Why?
|
| Platelet Endothelial Cell Adhesion Molecule-1 | 1 | 2002 | 26 | 0.010 |
Why?
|
| Growth Substances | 1 | 2002 | 113 | 0.010 |
Why?
|
| Lectins | 1 | 2002 | 48 | 0.010 |
Why?
|
| Cerium Radioisotopes | 1 | 1981 | 1 | 0.010 |
Why?
|
| Strontium Radioisotopes | 1 | 1981 | 2 | 0.010 |
Why?
|
| Ruthenium | 1 | 1981 | 4 | 0.010 |
Why?
|
| Tolbutamide | 1 | 1981 | 5 | 0.010 |
Why?
|
| Capillaries | 1 | 2002 | 70 | 0.010 |
Why?
|
| Heterozygote | 1 | 2004 | 681 | 0.010 |
Why?
|
| Myocardial Revascularization | 1 | 2002 | 96 | 0.010 |
Why?
|
| Genetic Vectors | 1 | 2005 | 973 | 0.010 |
Why?
|
| Dietary Proteins | 1 | 1983 | 237 | 0.010 |
Why?
|
| Anti-Bacterial Agents | 1 | 1972 | 2391 | 0.010 |
Why?
|
| Ultrafiltration | 1 | 1980 | 12 | 0.010 |
Why?
|
| Phosphocreatine | 1 | 1980 | 9 | 0.010 |
Why?
|
| Endoplasmic Reticulum | 2 | 1973 | 213 | 0.010 |
Why?
|
| Prosthesis Design | 1 | 2004 | 665 | 0.010 |
Why?
|
| Phosphorylase Phosphatase | 1 | 1980 | 1 | 0.010 |
Why?
|
| 3',5'-Cyclic-GMP Phosphodiesterases | 1 | 1980 | 38 | 0.010 |
Why?
|
| Absorption | 1 | 1980 | 52 | 0.010 |
Why?
|
| Sex Factors | 1 | 2004 | 1236 | 0.010 |
Why?
|
| Microscopy, Fluorescence | 1 | 2002 | 331 | 0.010 |
Why?
|
| Infusions, Parenteral | 3 | 1985 | 100 | 0.010 |
Why?
|
| Aspartic Acid | 1 | 1980 | 75 | 0.010 |
Why?
|
| Catheters, Indwelling | 1 | 1981 | 156 | 0.010 |
Why?
|
| Electrophysiology | 1 | 1981 | 269 | 0.010 |
Why?
|
| Ligands | 2 | 1996 | 534 | 0.010 |
Why?
|
| Membrane Proteins | 2 | 1999 | 1526 | 0.010 |
Why?
|
| Diffusion Chambers, Culture | 1 | 1999 | 6 | 0.010 |
Why?
|
| Genotype | 1 | 2006 | 2534 | 0.010 |
Why?
|
| Hepatic Veins | 3 | 1985 | 23 | 0.010 |
Why?
|
| Compliance | 1 | 1979 | 17 | 0.010 |
Why?
|
| Protons | 1 | 1980 | 91 | 0.010 |
Why?
|
| Interphase | 1 | 1999 | 45 | 0.010 |
Why?
|
| Adrenergic alpha-Agonists | 1 | 1979 | 22 | 0.010 |
Why?
|
| Injections, Subcutaneous | 1 | 1999 | 126 | 0.010 |
Why?
|
| Blotting, Western | 1 | 2002 | 1106 | 0.010 |
Why?
|
| Calcium Isotopes | 2 | 1969 | 6 | 0.010 |
Why?
|
| Adrenergic beta-Agonists | 1 | 1979 | 92 | 0.010 |
Why?
|
| Radionuclide Ventriculography | 1 | 1999 | 5 | 0.010 |
Why?
|
| Gamma Cameras | 1 | 1999 | 6 | 0.010 |
Why?
|
| Palmitoyl Coenzyme A | 1 | 1979 | 2 | 0.010 |
Why?
|
| Contractile Proteins | 1 | 1979 | 17 | 0.010 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 1980 | 287 | 0.010 |
Why?
|
| Anesthesia | 1 | 2002 | 209 | 0.010 |
Why?
|
| Acyl Coenzyme A | 1 | 1979 | 24 | 0.010 |
Why?
|
| Phosphoproteins | 1 | 1981 | 401 | 0.010 |
Why?
|
| Carnitine O-Palmitoyltransferase | 1 | 1979 | 25 | 0.010 |
Why?
|
| Quaternary Ammonium Compounds | 1 | 1978 | 27 | 0.010 |
Why?
|
| Algorithms | 1 | 2005 | 1577 | 0.010 |
Why?
|
| Receptors, Cholinergic | 1 | 1978 | 84 | 0.010 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 1 | 1978 | 98 | 0.010 |
Why?
|
| Piroxicam | 1 | 1997 | 2 | 0.010 |
Why?
|
| Zymosan | 1 | 1997 | 6 | 0.010 |
Why?
|
| Radiation Chimera | 1 | 1997 | 14 | 0.010 |
Why?
|
| Disease Progression | 1 | 2004 | 1994 | 0.010 |
Why?
|
| Echocardiography, Doppler | 1 | 1998 | 172 | 0.010 |
Why?
|
| Naproxen | 1 | 1997 | 20 | 0.010 |
Why?
|
| Mice, Inbred mdx | 1 | 1997 | 40 | 0.010 |
Why?
|
| Tromethamine | 1 | 1977 | 9 | 0.010 |
Why?
|
| Hyperbaric Oxygenation | 2 | 1969 | 20 | 0.010 |
Why?
|
| Receptors, Nicotinic | 1 | 1978 | 154 | 0.010 |
Why?
|
| Whole-Body Irradiation | 1 | 1997 | 66 | 0.010 |
Why?
|
| Culture Media, Conditioned | 1 | 1997 | 80 | 0.010 |
Why?
|
| Amylases | 1 | 1977 | 26 | 0.010 |
Why?
|
| Cell Line, Transformed | 1 | 1997 | 172 | 0.010 |
Why?
|
| Lymphocyte Activation | 1 | 1999 | 681 | 0.010 |
Why?
|
| Peroxidase | 1 | 1997 | 61 | 0.010 |
Why?
|
| Thioglycolates | 1 | 1997 | 5 | 0.010 |
Why?
|
| Methylprednisolone | 1 | 1997 | 90 | 0.010 |
Why?
|
| Sarcomeres | 1 | 1997 | 30 | 0.010 |
Why?
|
| Logistic Models | 1 | 2002 | 1768 | 0.010 |
Why?
|
| Guanylate Cyclase | 1 | 1977 | 37 | 0.010 |
Why?
|
| Phosphoric Diester Hydrolases | 1 | 1977 | 63 | 0.010 |
Why?
|
| Crosses, Genetic | 1 | 1997 | 160 | 0.010 |
Why?
|
| DNA | 1 | 2002 | 1606 | 0.010 |
Why?
|
| Peritonitis | 1 | 1997 | 76 | 0.010 |
Why?
|
| Heart Sounds | 1 | 1976 | 9 | 0.010 |
Why?
|
| Protein Kinase Inhibitors | 2 | 1977 | 520 | 0.010 |
Why?
|
| Ascites | 1 | 1997 | 88 | 0.010 |
Why?
|
| Receptor Aggregation | 1 | 1996 | 7 | 0.010 |
Why?
|
| Immunoglobulin Fc Fragments | 1 | 1996 | 26 | 0.010 |
Why?
|
| Cell Nucleus | 1 | 1979 | 679 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2003 | 2794 | 0.010 |
Why?
|
| Corrosion Casting | 1 | 1995 | 3 | 0.010 |
Why?
|
| Mice, SCID | 1 | 1997 | 572 | 0.010 |
Why?
|
| Tetrazolium Salts | 1 | 1995 | 15 | 0.010 |
Why?
|
| Methods | 2 | 1972 | 149 | 0.010 |
Why?
|
| Hypoxia | 1 | 1977 | 246 | 0.010 |
Why?
|
| Receptors, Very Late Antigen | 1 | 1995 | 5 | 0.010 |
Why?
|
| Coloring Agents | 1 | 1995 | 77 | 0.010 |
Why?
|
| Mice, Inbred CBA | 1 | 1995 | 30 | 0.010 |
Why?
|
| Cell Polarity | 1 | 1996 | 125 | 0.010 |
Why?
|
| Platelet Adhesiveness | 1 | 1995 | 40 | 0.010 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 1997 | 302 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 1988 | 8113 | 0.010 |
Why?
|
| Anti-Inflammatory Agents | 1 | 1997 | 278 | 0.010 |
Why?
|
| Pharmacology | 2 | 1965 | 10 | 0.010 |
Why?
|
| Metabolic Clearance Rate | 2 | 1985 | 142 | 0.010 |
Why?
|
| Astrocytes | 1 | 1997 | 250 | 0.010 |
Why?
|
| Diabetes Complications | 1 | 1976 | 194 | 0.010 |
Why?
|
| Life Tables | 1 | 1994 | 28 | 0.010 |
Why?
|
| Hepatic Artery | 2 | 1985 | 52 | 0.010 |
Why?
|
| Receptors, Interleukin-2 | 1 | 1994 | 43 | 0.010 |
Why?
|
| Endocardium | 1 | 1994 | 48 | 0.010 |
Why?
|
| Geriatrics | 2 | 1965 | 72 | 0.010 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 1994 | 158 | 0.010 |
Why?
|
| Anti-Arrhythmia Agents | 1 | 1976 | 218 | 0.010 |
Why?
|
| Azides | 1 | 1973 | 10 | 0.010 |
Why?
|
| Immunoglobulin G | 1 | 1997 | 772 | 0.010 |
Why?
|
| Computers | 1 | 1973 | 66 | 0.010 |
Why?
|
| Models, Chemical | 1 | 1973 | 86 | 0.010 |
Why?
|
| Corn Oil | 1 | 1993 | 11 | 0.010 |
Why?
|
| Immunochemistry | 1 | 1992 | 30 | 0.010 |
Why?
|
| Statistics as Topic | 1 | 1973 | 243 | 0.010 |
Why?
|
| Immune Sera | 1 | 1992 | 95 | 0.010 |
Why?
|
| Carboxylic Acids | 1 | 1972 | 24 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 1996 | 773 | 0.010 |
Why?
|
| Pacemaker, Artificial | 1 | 1975 | 170 | 0.010 |
Why?
|
| Arsenic | 1 | 1973 | 46 | 0.010 |
Why?
|
| Muscle Development | 1 | 1972 | 71 | 0.010 |
Why?
|
| Fish Oils | 1 | 1993 | 82 | 0.010 |
Why?
|
| Palmitic Acids | 2 | 1973 | 14 | 0.010 |
Why?
|
| Smoking | 1 | 1978 | 1027 | 0.010 |
Why?
|
| Fatty Acids, Omega-3 | 1 | 1993 | 69 | 0.010 |
Why?
|
| Carbon Isotopes | 2 | 1973 | 272 | 0.010 |
Why?
|
| Quinidine | 2 | 1976 | 9 | 0.010 |
Why?
|
| Temperature | 1 | 1972 | 304 | 0.010 |
Why?
|
| Intraoperative Period | 1 | 1990 | 73 | 0.010 |
Why?
|
| Biopsy | 1 | 1994 | 1252 | 0.010 |
Why?
|
| Plastics | 1 | 1990 | 16 | 0.010 |
Why?
|
| Glutathione Disulfide | 1 | 1989 | 20 | 0.010 |
Why?
|
| Thyroid Hormones | 1 | 1970 | 66 | 0.010 |
Why?
|
| Centrifugation, Density Gradient | 1 | 1969 | 97 | 0.010 |
Why?
|
| Fluorides | 1 | 1969 | 18 | 0.010 |
Why?
|
| Complement Fixation Tests | 1 | 1989 | 33 | 0.010 |
Why?
|
| Postoperative Period | 1 | 1990 | 330 | 0.010 |
Why?
|
| Partial Pressure | 1 | 1988 | 28 | 0.010 |
Why?
|
| Norepinephrine | 1 | 1969 | 174 | 0.010 |
Why?
|
| Radiography | 2 | 1968 | 807 | 0.000 |
Why?
|
| Virulence Factors, Bordetella | 1 | 1987 | 19 | 0.000 |
Why?
|
| Pertussis Toxin | 1 | 1987 | 24 | 0.000 |
Why?
|
| Cholera Toxin | 1 | 1987 | 45 | 0.000 |
Why?
|
| Acetyl-CoA C-Acyltransferase | 1 | 1987 | 2 | 0.000 |
Why?
|
| Molecular Conformation | 1 | 1987 | 95 | 0.000 |
Why?
|
| Reference Values | 1 | 1988 | 695 | 0.000 |
Why?
|
| Electron Spin Resonance Spectroscopy | 1 | 1987 | 22 | 0.000 |
Why?
|
| Spin Labels | 1 | 1987 | 39 | 0.000 |
Why?
|
| Coronary Artery Bypass | 1 | 1990 | 486 | 0.000 |
Why?
|
| Myosins | 2 | 1978 | 46 | 0.000 |
Why?
|
| Splanchnic Circulation | 1 | 1986 | 52 | 0.000 |
Why?
|
| Sulfates | 1 | 1985 | 33 | 0.000 |
Why?
|
| Retrospective Studies | 1 | 2004 | 15879 | 0.000 |
Why?
|
| Receptor, Insulin | 1 | 1985 | 67 | 0.000 |
Why?
|
| Hypoglycemia | 1 | 1967 | 191 | 0.000 |
Why?
|
| Oxotremorine | 1 | 1985 | 2 | 0.000 |
Why?
|
| Quinuclidinyl Benzilate | 1 | 1985 | 3 | 0.000 |
Why?
|
| Adolescent | 1 | 2004 | 18984 | 0.000 |
Why?
|
| Guanosine Diphosphate | 1 | 1985 | 13 | 0.000 |
Why?
|
| Infusions, Intravenous | 1 | 1986 | 539 | 0.000 |
Why?
|
| Basal Metabolism | 1 | 1965 | 89 | 0.000 |
Why?
|
| Portal System | 1 | 1984 | 33 | 0.000 |
Why?
|
| Glossopharyngeal Nerve | 1 | 1964 | 7 | 0.000 |
Why?
|
| Glossopharyngeal Nerve Diseases | 1 | 1964 | 5 | 0.000 |
Why?
|
| Phenytoin | 1 | 1964 | 64 | 0.000 |
Why?
|
| Neuralgia | 1 | 1964 | 44 | 0.000 |
Why?
|
| Syncope | 1 | 1964 | 52 | 0.000 |
Why?
|
| Oximetry | 1 | 1965 | 160 | 0.000 |
Why?
|
| Drug Therapy | 1 | 1964 | 87 | 0.000 |
Why?
|
| Iodine Radioisotopes | 1 | 1983 | 75 | 0.000 |
Why?
|
| Meat | 1 | 1983 | 49 | 0.000 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 1983 | 339 | 0.000 |
Why?
|
| Renal Circulation | 1 | 1982 | 45 | 0.000 |
Why?
|
| Indomethacin | 1 | 1982 | 84 | 0.000 |
Why?
|
| Anesthesia, General | 1 | 1983 | 111 | 0.000 |
Why?
|
| Coronary Vessel Anomalies | 1 | 1966 | 269 | 0.000 |
Why?
|
| Eating | 1 | 1983 | 351 | 0.000 |
Why?
|
| Pain | 1 | 1964 | 446 | 0.000 |
Why?
|
| Arginine | 1 | 1983 | 303 | 0.000 |
Why?
|
| Software | 1 | 1985 | 672 | 0.000 |
Why?
|
| Hexamethonium Compounds | 1 | 1978 | 6 | 0.000 |
Why?
|
| 1-Methyl-3-isobutylxanthine | 1 | 1978 | 15 | 0.000 |
Why?
|
| Theophylline | 1 | 1978 | 29 | 0.000 |
Why?
|
| Pilocarpine | 1 | 1978 | 14 | 0.000 |
Why?
|
| Citric Acid Cycle | 1 | 1979 | 44 | 0.000 |
Why?
|
| Hindlimb | 1 | 1978 | 76 | 0.000 |
Why?
|
| Carbon Monoxide Poisoning | 1 | 1978 | 7 | 0.000 |
Why?
|
| Murexide | 1 | 1977 | 1 | 0.000 |
Why?
|
| Hypothermia, Induced | 1 | 1979 | 158 | 0.000 |
Why?
|
| Protein Denaturation | 1 | 1977 | 50 | 0.000 |
Why?
|
| Hot Temperature | 1 | 1977 | 135 | 0.000 |
Why?
|
| Culture Media | 1 | 1977 | 183 | 0.000 |
Why?
|
| Procainamide | 1 | 1976 | 4 | 0.000 |
Why?
|
| Nephrons | 1 | 1976 | 20 | 0.000 |
Why?
|
| Blood Urea Nitrogen | 1 | 1976 | 70 | 0.000 |
Why?
|
| Acid-Base Imbalance | 1 | 1976 | 27 | 0.000 |
Why?
|
| Lidocaine | 1 | 1976 | 48 | 0.000 |
Why?
|
| Risk | 1 | 1978 | 739 | 0.000 |
Why?
|
| Receptors, Drug | 1 | 1975 | 38 | 0.000 |
Why?
|
| Mitochondria, Muscle | 1 | 1975 | 34 | 0.000 |
Why?
|
| Water-Electrolyte Imbalance | 1 | 1976 | 77 | 0.000 |
Why?
|
| Enzyme Inhibitors | 1 | 1977 | 581 | 0.000 |
Why?
|
| Tropomyosin | 1 | 1973 | 26 | 0.000 |
Why?
|
| NAD | 1 | 1973 | 50 | 0.000 |
Why?
|
| Cricetinae | 1 | 1973 | 411 | 0.000 |
Why?
|
| Culture Techniques | 1 | 1972 | 91 | 0.000 |
Why?
|
| Filtration | 1 | 1972 | 23 | 0.000 |
Why?
|
| Chick Embryo | 1 | 1972 | 131 | 0.000 |
Why?
|
| Pyruvates | 1 | 1969 | 21 | 0.000 |
Why?
|
| Xenon | 1 | 1969 | 11 | 0.000 |
Why?
|
| Angiocardiography | 1 | 1969 | 13 | 0.000 |
Why?
|
| Lactates | 1 | 1969 | 93 | 0.000 |
Why?
|
| Fatty Acids, Nonesterified | 1 | 1969 | 136 | 0.000 |
Why?
|
| Cadaver | 1 | 1966 | 132 | 0.000 |
Why?
|
| Child | 1 | 1978 | 24118 | 0.000 |
Why?
|